Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders
PUBLICATION BY MATTHIAS MAGOOLA, CHEMIST Abstract: Antibodies that can selectively remove rogue proteins in the brain are an obvious choice to treat neurodegenerative disorders (NDs), but after decades of efforts, only...